—Long-term Phase 1/2a and open label extension (OLE) data for zorevunersen on top of standard of care anti-seizure medicines (ASMs) demonstrate durable seizure reductions, including increases in ...
Long-term Phase 1/2a and open label extension (OLE) data for zorevunersen on top of standard of care anti-seizure medicines (ASMs)demonstrate ...
Stoke Therapeutics, Inc. , a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine, and Biogen Inc. today announced data presentations ...
The UN World Health Organization (WHO) has issued its first guideline on the use of a new class of weight-loss medicines.
WhoWhatWhy on MSNOpinion
What if the America we think we live in never existed?
We’re not one nation split by politics — we’re 11 regional cultures that have been at war since the colonies. And now the ...
A Nobel laureate, he identified an enzyme that cuts DNA, laying the groundwork for milestones in scientific research and ...
An archaeon reads the same codon in two different ways, overturning a doctrine that has stood for 60 years. Living organisms ...
PeptiDream Inc. ( OTCPK:PPTDF) Discusses Progress in Radiopharmaceuticals and Peptide Therapeutics Pipeline December 5, 2025 1:30 AM EST ...
Morning Overview on MSN
Sugars, gum-like compounds, and stardust found in Bennu
Asteroid Bennu was already a time capsule from the dawn of the Solar System, but the first detailed look at its returned ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback